Taking Aim At Recurrence: Targeting Cancer Stem Cells To Stop Proliferation
By
Pharmaceutical Approvals Monthly / Pharmaceutical Approvals Monthly June 2010, Vol. 15, No. 006
Pipeline Updates / Word Count: 2986 / Article # 06150060003
Executive Summary
An emerging field of oncology drug development offers the potential for eradicating all remaining cancer cells following treatment – and thus preventing recurrence – by targeting the so-called cancer stem cells that are thought to be involved in cancer proliferation, treatment resistance, and metastasis.
$125.00
Buy Now
For $125.00, purchase this 2986-word article and receive immediate online access. 100% Satisfaction Guarantee.
Already a Subscriber?
Log in for complete access.
Log In
Questions?
Call Toll-Free (800) 332-2181 or +1 (908) 547-2159.